EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+11.44%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$644M
AUM Growth
+$644M
(+98%)
Cap. Flow
+$295M
Cap. Flow
% of AUM
45.8%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
104
New
10
Increased
74
Reduced
–
Closed
3
Top Buys
| 1 |
Terex
TEX
|
$13.4M |
| 2 |
ROC
ROCKWOOD HLDGS INC
ROC
|
$12.7M |
| 3 |
ININ
Interactive Intelligence Group, inc.
ININ
|
$11.3M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$10.1M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$9.61M |
Top Sells
| 1 |
DWSN
DAWSON GEOPHYSICAL CO
DWSN
|
$2.21M |
| 2 |
Traws Pharma
TRAW
|
$264K |
| 3 |
VVUS
Vivus Inc
VVUS
|
$253K |
Sector Composition
| 1 | Healthcare | 23.69% |
| 2 | Consumer Discretionary | 13.71% |
| 3 | Technology | 11.28% |
| 4 | Industrials | 11% |
| 5 | Materials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ligand Pharmaceuticals
LGND
$3.25B
| $9.95M | 1.54% |
147,900
+13,500
| +10% | +$908K |
|
|
STKL
27
SunOpta
STKL
$741M
| $9.72M | 1.51% |
822,600
+288,600
| +54% | +$3.41M |
|
|
IPHI
28
DELISTED
INPHI CORPORATION
IPHI
| $9.71M | 1.51% |
603,300
+261,200
| +76% | +$4.2M |
|
29
Crown Castle
CCI
$42.3B
| $9.64M | 1.5% |
130,700
+85,900
| +192% | +$6.34M |
|
|
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $9.42M | 1.46% |
363,500
+190,200
| +110% | +$4.93M |
|
|
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
| $9.41M | 1.46% |
+411,900
| New | +$9.41M |
|
|
CXP
32
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $9.15M | 1.42% |
+335,800
| New | +$9.15M |
|
|
CPN
33
DELISTED
Calpine Corporation
CPN
| $8.87M | 1.38% |
424,100
+126,600
| +43% | +$2.65M |
|
34
ASML
ASML
$290B
| $8.76M | 1.36% |
93,800
+41,800
| +80% | +$3.9M |
|
|
NPSP
35
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $8.5M | 1.32% |
283,900
+41,200
| +17% | +$1.23M |
|
|
VMW
36
DELISTED
VMware, Inc
VMW
| $8.49M | 1.32% |
+78,600
| New | +$8.49M |
|
37
Sangamo Therapeutics
SGMO
$161M
| $8.36M | 1.3% |
462,500
+245,200
| +113% | +$4.43M |
|
38
Novavax
NVAX
$1.2B
| $7.89M | 1.22% |
1,740,900
+453,600
| +35% | +$2.05M |
|
39
Costamare
CMRE
$1.43B
| $7.74M | 1.2% |
360,200
+185,500
| +106% | +$3.99M |
|
|
AYR
40
DELISTED
Aircastle Limited
AYR
| $7.74M | 1.2% |
399,600
+77,100
| +24% | +$1.49M |
|
|
SDRL
41
DELISTED
Seadrill Limited Common Stock
SDRL
| $7.72M | 1.2% |
219,500
+76,200
| +53% | +$2.68M |
|
42
Oceaneering
OII
$2.37B
| $7.47M | 1.16% |
103,900
+22,100
| +27% | +$1.59M |
|
|
STML
43
DELISTED
Stemline Therapeutics, Inc.
STML
| $7.38M | 1.15% |
362,400
+154,300
| +74% | +$3.14M |
|
|
SCTY
44
DELISTED
SolarCity Corporation
SCTY
| $7.14M | 1.11% |
114,000
| – | – |
|
45
BorgWarner
BWA
$9.3B
| $6.92M | 1.07% |
112,600
| – | – |
|
46
Openlane
KAR
$3.05B
| $6.45M | 1% |
212,600
| – | – |
|
47
Franklin Covey
FC
$239M
| $6.24M | 0.97% |
315,600
+43,800
| +16% | +$866K |
|
48
Sarepta Therapeutics
SRPT
$1.98B
| $6.23M | 0.97% |
259,100
+117,300
| +83% | +$2.82M |
|
49
NRG Energy
NRG
$28.4B
| $6.15M | 0.95% |
193,400
| – | – |
|
|
LUMO
50
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $6.13M | 0.95% |
215,700
+58,400
| +37% | +$1.66M |
|